Gene Amplification Technologies Market Size | Companies
The gene amplification technologies market size was exhibited at USD 28.10 billion in 2024 and is projected to hit around USD 43.31 billion by 2034, growing at a CAGR of 4.42% during the forecast period 2024 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 29.34 Billion |
| Market Size by 2034 | USD 43.31 Billion |
| Growth Rate From 2024 to 2034 | CAGR of 4.42% |
| Base Year | 2024 |
| Forecast Period | 2024-2033 |
| Segments Covered | Technology, Application, Aample Type, Product, End use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America, Europe, Asia Pacific, Latin America, MEA |
| Key Companies Profiled | QIAGEN; New England Biolabs; Illumina Inc.; Yikang Gene; Bio-Rad Laboratories, Inc.; Menarini Silicon Biosystems; Merck KGaA; Promega Corporation; Takara Bio Inc.; Danaher Corporation; 4basebio; LGC Limited; Vazyme Biotech Co. Ltd.; MyBioSource.com. |
The increasing demand for research and development in molecular diagnostics, genomics, biological research, and genetic testing is a major driver of market expansion. The continued creation of multiple diagnostic tests utilizing different gene amplification techniques for COVID-19 has additionally boosted the market.
The market is significantly driven by the rapidly growing field of advanced DNA replication technologies. Due to advancements in technology in loop-mediated amplification, alternatives such as Nucleic Acid Sequence Based Amplification (NASBA), Rolling Circle Amplification (RCA), and Loop-Mediated Isothermal Amplification (LAMP) have been thoroughly researched.
These methods are gaining more popularity as they require no expensive thermal cyclers, have fast amplification rates, and can easily multiply from a single cell. These factors are anticipated to boost the utilization of products available in this market and in turn enhance the natural revenue generation.
The kits and reagents segment accounted for the largest revenue share of 68.1% in 2024. The segment growth is anticipated to be boosted during the forecast period by the increasing demand for kits and reagents in molecular diagnostics and genomics research, along with a multitude of companies providing a variety of kits, media, and reagents. Due to the extensive use of PCR-based amplification, numerous companies provide PCR instruments. Due to the rising use of gene amplification technologies, companies in the market are concentrating on launching innovative new products in this sector.
Software & services is expected to register the fastest CAGR of 2.2% during the forecast period. The gene amplification technologies software & services sector is expected to grow further due to the growing complexity of gene amplification techniques, higher need for personalized medicine, improvements in bioinformatics and cloud computing, and regulatory mandates. Advanced gene amplification methods such as next-generation sequencing (NGS) produce large volumes of data that necessitate complex software for analysis and understanding. Effective software solutions are vital for the management and organization of extensive datasets, guaranteeing data integrity and accessibility.
The Polymerase Chain Reaction (PCR)-bases amplification segment accounted for the largest share of 72.0% in 2024. The widespread utilization of PCR technology in various end-use applications is responsible for this. In addition, various technological challenges associated to PCR technology have encouraged the advancement and adoption of alternative technologies such as Loop-Mediated Isothermal Amplification (LAMP) and Multiple Displacement Amplification. Eiken Chemical Co., Ltd. and HiberGene Diagnostics are among the companies that have developed new tests for identifying the SARS-CoV-2 virus, utilizing LAMP technology.
Nucleic Acid Sequence Based Amplification is projected to grow at the fastest CAGR of 1.4% over the forecast period due to its high sensitivity and specificity, possibility of work at a constant temperature, flexibility of the technique, short time to complete the reaction, compatibility with robotic systems and new areas of usage. Nucleic Acid Sequence Based Amplification provides high sensitivity and specificity that allows using this technique for identification of low concentrations of target nucleic acids in different samples. These characteristics make Nucleic Acid Sequence Based Amplification particularly suitable for such applications as, for instance, the detection of infectious diseases, genetic testing, or cancer.
The Diagnostics and Pharmaceutical segment captures the largest revenue share of 72.7% in 2024. This is due to diagnostic tests for genetic diseases and disorders often utilize gene amplification techniques. These technologies are also used in the early identification and management of patients by assisting in early recognition of cancer and other conditions. Moreover, the increasing need for personalized care and specific medications is also contributing to the revenue increase in this sector.
The forensic and paternity testing segment is expected to register the fastest CAGR of 2.1% during the forecast period due to improved precision and sensitivity, broadening use cases, technological progress, growing crime levels, legal and regulatory demands, and government funding. Technological advancements have resulted in the creation of more compact gene amplification tools, facilitating the ability to perform tests at crime scenes or in distant areas. This allows for quick analysis at the location, speeding up investigations and enhancing the effectiveness of law enforcement.
The cell lines segment held the largest revenue share of 39.8% in 2024. This can be attributed to the wide availability of products for amplification using cell line samples. These kits are available at low prices and are easy to use, thereby increasing their usage in the market. The development of more robust and reliable cell lines has expanded their applications in gene amplification research and diagnostics. These advancements have led to increased efficiency and reproducibility in experiments, driving the growth of the cell lines segment.
Agricultural & food sample is projected to grow at the fastest CAGR over the forecast period. Gene amplification techniques are used for genetic modification and analysis in agricultural biotechnology, leading to the development of crops with improved traits such as yield, resistance to pests and diseases, and nutritional value. The growing adoption of agricultural biotechnology is driving the demand for gene amplification technologies in this sector.
The Academic and Research Institutes segment captured the largest revenue share of 27.0% in 2024. Academic and research institutions lead in essential research, advancing gene amplification technologies and their uses. These organizations are essential for progressing scientific knowledge and comprehension, aiding in the general growth of the discipline. Educational institutions have the duty of teaching and preparing future scientists and researchers in gene amplification technologies. Investing in education is leading to the development of a talented workforce, which is fueling advancement and expansion in the market.
The forensic labs segment is projected to grow at the second largest revenue share of 24.9% in 2024. DNA evidence is becoming more widely acknowledged as an effective tool for resolving crimes, offering robust and dependable evidence in legal proceedings. This growing dependence is fueling the need for forensic labs and their services, leading to the expansion of the sector. Governments are dedicating resources to improve forensic science infrastructure and provide training to strengthen law enforcement agencies' capacities. This investment is fueling the expansion of forensic labs by boosting demand and easing the uptake of new technologies.
North America dominated the gene amplification technologies market in 2024. The increasing need for gene amplification technologies in this area can be attributed to its hosting of some of the largest biotechnology and pharmaceutical companies globally. Also, another contributing factor to the growth of market revenue in this region is the support of government programs that aid in biotechnology Research & Development (R&D). Additionally, the region is anticipated to experience growth in market revenue due to substantial investments in genomics research and the demand for personalized treatment options.
U.S. Gene Amplification Technologies Market Trends
The Gene Amplification Technologies market in the U.S. dominated the market share with a share of 84.2% in 2024 due to the increasing popularity of molecular diagnostics for cancer presence of major market players and highly developed healthcare infrastructure in this region. The U.S. government's growing financial support for medical research and infrastructure is expected to drive the growth of the gene amplification technologies market in the country, leading to significant advancements in genomics within the healthcare sector.
Europe Gene Amplification Technologies Market Trends
Europe Gene Amplification Technologies market in the Europe dominated the market share with share of 26.3% in 2024 due to the abundance of leading manufacturers of gene amplification technologies. Furthermore, the market revenue growth of this region is anticipated to be boosted by government programs backing biotechnology R&D and increasing demand for personalized treatment in the upcoming forecast period.
UK Gene Amplification Technologies market is expected to grow rapidly in the coming years due to rapid evolution of DNA sequencing technologies in the recent years. The research and development or in other words the scientific study conducted in the UK has been remarkable and impressive due to presence of many universities and research centers of world class. The UK government offer a massive support for research and development across different fields such as the life sciences and biotechnology. The NHS is one of the most extensive and oldest healthcare systems globally, and for that reason, the healthcare requirement for diagnostic tools and technology is high.
Asia Pacific Gene Amplification Technologies Market Trends
Asia Pacific is anticipated to experience rapid growth during the forecast period due to supportive government efforts to enhance healthcare infrastructure. Growing research in genomics and molecular diagnostics, along with the abundant skilled workforce, have contributed to market expansion in developing countries such as China and India. In addition, the growth of market revenue in this region is anticipated to be driven by higher investments in R&D and healthcare infrastructure, as well as the increasing availability of skilled labor and affordable manufacturing options in countries such as China and India.
China Gene Amplification Technologies marketheld a substantial market share in 2024. There is an anticipated increase in the demand for whole genome amplification in China during the expected timeframe. The rise of the industry is due to the higher occurrence of different illnesses and the increasing demand for genetic research in the nation. The government in China is expected to increase the need for whole genome amplification through the implementation of beneficial healthcare projects.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the gene amplification technology market
Technology
Application
Sample Type
Product
End Use
Regional
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers